World journal of gastrointestinal pathophysiology

Using CRISPR gene editing in stomach cancer: how it works, recent progress, and treatment possibilities

Updated

Abstract

CRISPR/Cas9 technology may significantly enhance understanding and treatment of gastric cancer.

  • CRISPR/Cas9 is being used to identify oncogenes and tumor suppressors associated with gastric cancer.
  • Modeling interactions within the tumor microenvironment is facilitated by CRISPR/Cas9 applications.
  • Recent advances in genome editing have improved knowledge of gastric cancer development and resistance to treatments.
  • Therapeutic gene editing using CRISPR/Cas9 faces challenges, including off-target effects and delivery methods.
  • Ethical considerations are an important aspect of implementing CRISPR/Cas9 in gastric cancer therapy.

Simplified

Full Text

We can’t show the full text here under this license.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free